| S. No. | Compound | CAS No. |
| 1 | Benzamide, 2-chloro-N-(4′,6-dimethoxy[1,1′-biphenyl]-3-yl)-4-fluoro- | 930470-97-6 |
| 2 | 2-Hydroxy-N-(5-nitro-2-thiazolyl)benzamide | 173903-47-4 |
| 3 | 2-Indolizinecarboxylic acid, ethyl ester | 153274-63-6 |
| 4 | Ethyl 2-chloroformylpropionate | 50496-34-9 |
| 5 | Isopropyl trifluoromethanesulfonate | 41029-44-1 |
| 6 | 2-Aminoindole | 36946-70-0 |
| 7 | 4-Ethylpyrimidine | 30537-73-6 |
| 8 | 4′,6-Diamidino-2-phenylindole dihydrochloride | 28718-90-3 |
| 9 | (Cyanomethylene)triphenylphosphorane | 16640-68-9 |
| 10 | cis-1,2-Bis(hydroxymethyl)cyclohexane | 15753-50-1 |
| 11 | 2-Indolizinecarboxylic acid, 1-cyano-, ethyl ester | 6/9/3243 |
| 12 | Nonanedioic acid, monoethyl ester | 1593-55-1 |
| 13 | N-(4-methyl-3-(trifluoromethyl)phenyl)-2-(4-(6-(4-(piperazine-1-carbonyl)phenyl)imidazo[1,2-a]pyridin-3-yl)phenoxy)acetamide | NA |
| 14 | N-(4-methyl-3-(trifluoromethyl)phenyl)-2-(4-(6-(4-(morpholine-4-carbonyl)phenyl)imidazo[1,2-a]pyridin-3-yl)phenoxy)acetamide | NA |
| 15 | 2-Hydroxybenzoyl chloride | 1441-87-8 |
| 16 | Ethyl 2-(hydroxy(pyridin-2-yl)methyl)acrylate | 153274-52-3 |
| 17 | 3-Ethoxy-2-methyl-3-oxopropanoic acid | 2985-33-3 |
| 18 | 6-Ethylpyrimidin-4(5H)-one | NA |
| 19 | 4-Chloro-6-ethylpyrimidine | 141602-25-7 |
| 20 | (3-Bromophenyl)hydrazine hydrochloride | 27246-81-7 |
| 21 | 1-(3-Bromophenyl)-2-(1-(4-bromophenyl)ethylidene)hydrazine | 33732-13-7 |
| 22 | 6-Bromo-2-(4-bromophenyl)-1H-indole | 28718-96-9 |
| 23 | 2-(4-Cyanophenyl)-1H-indole-6-carbonitrile | 28719-00-8 |
| 24 | 2-(Pyridin-2-yl)acetonitrile | 2739-97-1 |
| 25 | 2H-Pyrido[3,2-b][1,4]oxazin-3(4H)-one | 20348-09-8 |
| 26 | 3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine | 20348-23-6 |
| 27 | 4-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-4-ium | NA |
| 28 | 6-chloro-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine | 1260665-94-8 |
| 29 | 4′,6-dimethoxybiphenyl-3-amine | 900640-92-8 |
| 30 | 6-bromo-2-iodoimidazo[1,2-a]pyridine | 1935240-57-5 |
| 31 | 4-(6-bromoimidazo[1,2-a]pyridin-2-yl)phenol | 956499-75-5 |
| 32 | 2-(4-(6-bromoimidazo[1,2-a]pyridin-2-yl)phenoxy)-N-(4-methyl-3-(trifluoromethyl)phenyl)acetamide | NA |
| 33 | ethyl 4-(2-(4-(2-(4-methyl-3-(trifluoromethyl)phenylamino)-2-oxoethoxy)phenyl)imidazo[1,2-a]pyridin-6-yl)benzoate | NA |
| 34 | 4-(2-(4-(2-(4-methyl-3-(trifluoromethyl)phenylamino)-2-oxoethoxy)phenyl)imidazo[1,2-a]pyridin-6-yl)benzoic acid | NA |
| 35 | BP002a03 (Impurity of antifungal SCH-51048) | NA |
| 36 | BP001a02 BP002a03 (Impurity of antifungal SCH-51048) | NA |
| 37 | BP001a01 BP002a03 (Impurity of antifungal SCH-51048) | NA |
| 38 | BP001a03 BP002a03 (Impurity of antifungal SCH-51048) | NA |
| 39 | BP004b03 BP002a03 (Impurity of antifungal SCH-51048) | NA |
| 40 | L-Glutamicacid, 1-ethyl ester | 52454-78-1 |
| 41 | (Z)-9-octadecenal | 2423-10-1 |
| 42 | (2Z)-4-(dimethylamino)but-2-enoic acid | NA |
| 43 | 2,6-dichlorophenacyl chloride | 81547-71-9 |
| 44 | 3-({2-[(2-Cyanophenylamino)-methyl]-1-methyl-1H-benzoimidazole-5-carbonyl}-pyridin-2-yl-amino)-propionic acid ethyl ester (DABIGATRAN imp) | NA |
| 45 | 3-({2-[(4-Cyanophenylamino)-methyl]-1-methyl-1H-benzoimidazole-5-carbonyl}-pyridin-2-yl-amino)-propionic acid ((DABIGATRAN imp) | 212322-77-5 |
| 46 | 3-({2-[(4-Cyanophenylamino)-methyl]-1-methyl-1H-benzoimidazole-5-carbonyl}-pyridin-2-yl-amino)-propionic acid methyl ester (DABIGATRAN imp) | 211916-39-1 |
| 47 | 3-({2-[(2-Cyanophenylamino)-methyl]-1-methyl-1H-benzoimidazole-5-carbonyl}-pyridin-2-yl-amino)-propionic acid ethyl ester (DABIGATRAN imp) | NA |
| 48 | ethyl 3-(1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate (DABIGATRAN imp) | 1702936-92-2 |
| 49 | 4-Methyl-2-phenylaniline | 42308-28-1 |
| 50 | Ethanesulfonyl chloride, 2-amino-, hydrochloride | 34817-62-4 |
| 51 | Rocuronium Related Compound A | 119302-24-8 |
| 52 | Rocuronium Related Compound G | 119302-20-4 |
| 53 | 1-(Aminomethyl)cyclohexaneacetic Acid | 60142-96-3 |
| 54 | Gabapentin Ethyl Ester Hydrochloride | 60175-04-4 |
| 55 | Gabapentin Related Compound A | 64744-50-9 |
| 56 | Gabapentin Related Compound E | 67950-95-2 |
| 57 | Methyl Gabapentin Ester | 138799-98-1 |
| 58 | 3,3-Pentamethylene Glutarimide | 1130-32-1 |
| 59 | Allylestrenol | 432-60-0 |
| 60 | Lynestrenol | 52-76-6 |
| 61 | Levonorgestrel | 17489-40-6 |
| 62 | Ethylestrenol | 965-90-2 |
| 63 | Estradiol | 50-28-2 |
| 64 | Nandrolone decanoate | 360-70-3 |
| 65 | Nandrolone undecanoate | 862-89-5 |
| 66 | Testosterone | 58-22-0 |
| 67 | Hydrocortisone | 50-23-7 |
| 68 | Azithromycin Impurity N | 612069-25-7 |
| 69 | Azithromycin Impurity F | 612069-28-0 |
| 70 | Azithromycin Impurity M | 765927-71-7 |
| 71 | Azithromycin Impurity E | 612069-27-9 |
| 72 | Azithromycin Impurity I | 172617-84-4 |
| 73 | Azithromycin Impurity J | 117693-41-1 |
| 74 | Azithromycin Impurity L | 90503-06-3 |
| 75 | Azithromycin Impurity F | 612069-26-8 |
| 76 | Rifaximin | 80621-81-4 |
| 77 | Rifaximin-Impurity-A[4-Methylpyridin-2-amine ] | 695-34-1 |
| 78 | Rifamycin SV-Impurity-C | 6998-60-3 |
| 79 | Rifamycin-S- Impurity-E | 13553-79-2 |
| 80 | Rifamycin-Impurity-G | 80621-76-7 |
| 81 | 25-Desacetyl Rifaximin | 80621-88-1 |
| 82 | 25-Desacetyl Rifamycin-S | 17555-51-0 |
| 83 | Imatinib Mesylate | 152459-95-5 |
| 84 | Imatinib-[(2E)-3-(dimethyl amino)1- (pyridin-3-yl)prop-2-en-1-one] | NA |
| 85 | Imatinib-[Impurity-A(4-methyl-N-{4-(pyridin-3-yl) pyrimidin-2-yl}benzene-1,3-diamine)] | 152460-10-1 |
| 86 | Imatinib-[N-(2-methyl-5-nitro phenyl) 4-pyridin-3-yl) pyrimidin-2- amine] | 152460-09-8 |
| 87 | Imatinib-[1-(pyridin-3-yl) ethan-1-one] | 350-03-8 |
| 88 | Lenalidomide | 191732-72-6 |
| 89 | Lenalidomide-[Methyl nitro benzoic acid] | 96-98-0 |
| 90 | Lenalidomide-[Methyl nitro-benzoate] | 59382-59-1 |
| 91 | Lenalidomide-[Bromo methyl nitro benzoate] | 98475-07-1 |
| 92 | Lenalidomide-[Nitro Lenalidomide] | 8227026-45-9 |
| 93 | Lenalidomide-[Amino piperidinedione hydrochloride] | 24666-56-6 |
| 94 | Pinaverium Bromide | |
| 95 | Pinaverium-[1-bromo-2-(bromo methyl)- 4,5-di methoxy benzene] | 882167-77-3 |
| 96 | Pinaverium-[3,4-Bis(2-Methoxyethoxy) benzonitrile] | 80407-68-7 |
| 97 | Pinaverium-[4,5-Bis(2-Methoxyethoxy) -2-Nitro benzonitrile] | 236750-65-5 |
| 98 | Pinaverium-[2-Amino-4,5-bis(2-Methoxy ethoxy) Benzonitrile] | 950596-58-4 |
| 99 | Pinaverium-[Erlotinib Base] | 183321-74-6 |
| 100 | Erlotinib hydrochloride | 183319-69-9 |
| 101 | Erlotinib-[2- Amino-4,5-bis (2-methoxy ethoxy benzonitrile] | 950596-58-4 |
| 102 | Erlotinib-[4,5-bis (2-methoxy ethoxy -2- nitro benzonitrile] | 236750-65-5 |
| 103 | Erlotinib-[6-O-Desmethyl Erlotinib] | 183321-86-0 |
| 104 | Erlotinib-[7-O-Desmethyl Erlotinib] | 183320-29-8 |
| 105 | Erlotinib-[Di-desmethyl Erlotinib] | 183320-29-8 |
| 106 | Sorafenib tosylate | 475207-59-1 |
| 107 | Sorafenib-[4-(4-amino phenoxy) -N-methylpyridine- 2-carboxamide] | 284462-37-9 |
| 108 | Sorafenib-[N-methyl-4- phenoxy pyridine- 2-carboxamide] | 2004659-85-0 |
| 109 | 1,4-phenyldiboronic acid | 4612-26-4 |
| 110 | 1-( tert-butoxycarbonyl)-1 H-imidazol-4-ylboronic acid pinacolate ester | NA |
| 111 | 1-( tert-butoxycarbonyl)-1 H-imidazol-4-ylboronic acid | NA |
| 112 | (1-tritylimidazol-4-yl)boronic acid | 207307-51-5 |
| 113 | Sorafenib-[N-methyl-4-[4-({[3- (trifluoromethyl) phenyl] carbamoyl} amino)phenoxy] pyridine- 2-carboxamide] | 1285533-84-7 |
| 114 | Sorafenib[4-[4-({[2-chloro-3- (trifluoromethyl)phenyl]carbamoyl}amino) phenoxy]-N-methylpyridine-2-carboxamide] | 1431697-81-2 |
| 115 | Sorafenib[1,3-bis[4-chloro-3-(trifluoromethyl)phenyl]urea] | 370-50-3 |
| 116 | Sorafenib-[4-chloro-N-methylpyridine-2-carboxamide] | 220000-87-3 |
| 117 | Sorafenib-[4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]pyridine-2- carboxamide] | 284461-71-1 |
| 118 | Sorafenib-[N-methyl-4-(4-{[2-(methyl carbamoyl) pyridin-4-yl]amino}phenoxy) pyridine- 2-carboxamide] | NA |
| 119 | Sorafenib-[4-chloro-3-(trifluoromethyl)aniline] | 320-51-4 |
| 120 | Ticagrelor | 274693-27-5 |
| 121 | N-Nitrosodimethylamine | 62-75-9 |
| 122 | 1,4-Phenylenediboronic acid | 4612-26-4 |
| 123 | Lenalidomide (API) >99.5% | 191732-72-6 |
| 124 | Methyl 2-methyl-3-nitrobenzoate (>98%) | 59382-59-1 |
| 125 | 2- bromo-3-nitobenzoic acid methyl ester (>99%) | 98475-07-1 |
| 126 | 3-(4-nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperdine-2,6-dione (99%) | 827026-45-9 |
| 127 | Rifaxime (EP) >99.5% | 80621-81-4 |
| 128 | Sorafenib tosylate (99%) | 475207-59-1 |
| 129 | 4-(4-aminophenoxy)-N-methylpyridine-2-carboxamide (>95%) | 284462-37-9 |
| 130 | 4-[4-({[4-chloro-3-(trifluromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamid (99%) | 284461-73-0 |
| 131 | Imatinib mesylate (BP) >99.5% | 220127-57-1 |
| 132 | Guanidine (2-methyl-5-nitrophenyl) >98.5% | 152490-07-6 |
| 133 | N-(2-methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine >98.5% | 152460-09-8 |
| 134 | 4-(bromomethyl)benzoic acid >98.5% | 6232-88-8 |
| 135 | 4-[(4-methoxylpiperazin-1-yl)methyl]benzoic acid dihydrochloride >98.5% | 106261-49-8 |
| 136 | Erlotinib hydrochloride >99% | 183319-69-9 |
| 137 | 3,4-Bis(2-methoxyethoxy) benzonitirle > 98% | 80407-68-7 |
| 138 | 4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile > 99% | 236750-65-5 |
| 139 | 2-amino-4,5-bis(2-methoxy ethoxy) benzonitrile | 950596-58-4 |
| 140 | Pinaverium bromide >99% | 53251-94-8 |
| 141 | 4-{2-[2-6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl}morpholine >90% | 38284-47-8 |